These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Leptin and the pituitary. Sone M; Osamura RY Pituitary; 2001; 4(1-2):15-23. PubMed ID: 11824504 [TBL] [Abstract][Full Text] [Related]
4. Galanin in the regulation of the hypothalamic-pituitary-adrenal axis (Review). Tortorella C; Neri G; Nussdorfer GG Int J Mol Med; 2007 Apr; 19(4):639-47. PubMed ID: 17334639 [TBL] [Abstract][Full Text] [Related]
5. Leptin inhibition of the hypothalamic-pituitary-adrenal axis in response to stress. Heiman ML; Ahima RS; Craft LS; Schoner B; Stephens TW; Flier JS Endocrinology; 1997 Sep; 138(9):3859-63. PubMed ID: 9275075 [TBL] [Abstract][Full Text] [Related]
6. Leptin and the hypothalamo-pituitary-adrenal stress axis. Roubos EW; Dahmen M; Kozicz T; Xu L Gen Comp Endocrinol; 2012 May; 177(1):28-36. PubMed ID: 22293575 [TBL] [Abstract][Full Text] [Related]
7. Cocaine- and amphetamine-regulated transcript activates the hypothalamic-pituitary-adrenal axis through a corticotropin-releasing factor receptor-dependent mechanism. Smith SM; Vaughan JM; Donaldson CJ; Rivier J; Li C; Chen A; Vale WW Endocrinology; 2004 Nov; 145(11):5202-9. PubMed ID: 15271883 [TBL] [Abstract][Full Text] [Related]
8. Effects of leptin replacement on hypothalamic-pituitary growth hormone axis function and circulating ghrelin levels in ob/ob mice. Luque RM; Huang ZH; Shah B; Mazzone T; Kineman RD Am J Physiol Endocrinol Metab; 2007 Mar; 292(3):E891-9. PubMed ID: 17122091 [TBL] [Abstract][Full Text] [Related]
9. The kappa-opioid receptor agonist MR-2034 stimulates the rat hypothalamic-pituitary-adrenal axis: studies in vivo and in vitro. Calogero AE; Scaccianoce S; Burrello N; Nicolai R; Muscolo LA; Kling MA; Angelucci L; D'Agata R J Neuroendocrinol; 1996 Aug; 8(8):579-85. PubMed ID: 8866244 [TBL] [Abstract][Full Text] [Related]
10. Centrally administered murine-leptin stimulates the hypothalamus-pituitary- adrenal axis through arginine-vasopressin. Morimoto I; Yamamoto S; Kai K; Fujihira T; Morita E; Eto S Neuroendocrinology; 2000 Jun; 71(6):366-74. PubMed ID: 10878498 [TBL] [Abstract][Full Text] [Related]
11. Sex difference in the relationship between the hypothalamic-pituitary-adrenal axis and sex hormones in obesity. Vicennati V; Ceroni L; Genghini S; Patton L; Pagotto U; Pasquali R Obesity (Silver Spring); 2006 Feb; 14(2):235-43. PubMed ID: 16571848 [TBL] [Abstract][Full Text] [Related]
12. Acute glucocorticoid pretreatment suppresses stress-induced hypothalamic-pituitary-adrenal axis hormone secretion and expression of corticotropin-releasing hormone hnRNA but does not affect c-fos mRNA or fos protein expression in the paraventricular nucleus of the hypothalamus. Ginsberg AB; Campeau S; Day HE; Spencer RL J Neuroendocrinol; 2003 Nov; 15(11):1075-83. PubMed ID: 14622438 [TBL] [Abstract][Full Text] [Related]
13. Leptin fails to blunt the lipopolysaccharide-induced activation of the hypothalamic-pituitary-adrenal axis in rats. Basharat S; Parker JA; Murphy KG; Bloom SR; Buckingham JC; John CD J Endocrinol; 2014 May; 221(2):229-34. PubMed ID: 24578293 [TBL] [Abstract][Full Text] [Related]
14. Insulin and obesity transform hypothalamic-pituitary-adrenal axis stemness and function in a hyperactive state. Werdermann M; Berger I; Scriba LD; Santambrogio A; Schlinkert P; Brendel H; Morawietz H; Schedl A; Peitzsch M; King AJF; Andoniadou CL; Bornstein SR; Steenblock C Mol Metab; 2021 Jan; 43():101112. PubMed ID: 33157254 [TBL] [Abstract][Full Text] [Related]
15. Leptin and the hypothalamic-pituitary-adrenal axis activity in women with different obesity phenotypes. Vettor R; Vicennati V; Gambineri A; Pagano C; Calzoni F; Pasquali R Int J Obes Relat Metab Disord; 1997 Aug; 21(8):708-11. PubMed ID: 15481773 [TBL] [Abstract][Full Text] [Related]
16. Secretin, glucagon, gastric inhibitory polypeptide, parathyroid hormone, and related peptides in the regulation of the hypothalamus- pituitary-adrenal axis. Nussdorfer GG; Bahçelioglu M; Neri G; Malendowicz LK Peptides; 2000 Feb; 21(2):309-24. PubMed ID: 10764961 [TBL] [Abstract][Full Text] [Related]
17. Role of VIP, PACAP, and related peptides in the regulation of the hypothalamo-pituitary-adrenal axis. Nussdorfer GG; Malendowicz LK Peptides; 1998; 19(8):1443-67. PubMed ID: 9809661 [TBL] [Abstract][Full Text] [Related]
18. Vasopressin and the regulation of hypothalamic-pituitary-adrenal axis function: implications for the pathophysiology of depression. Scott LV; Dinan TG Life Sci; 1998; 62(22):1985-98. PubMed ID: 9627097 [TBL] [Abstract][Full Text] [Related]
19. Neuroregulation of the hypothalamus-pituitary-adrenal (HPA) axis in humans: effects of GABA-, mineralocorticoid-, and GH-Secretagogue-receptor modulation. Giordano R; Pellegrino M; Picu A; Bonelli L; Balbo M; Berardelli R; Lanfranco F; Ghigo E; Arvat E ScientificWorldJournal; 2006 Jan; 6():1-11. PubMed ID: 16432622 [TBL] [Abstract][Full Text] [Related]
20. Alterations in hypothalamic-pituitary-adrenal axis activity and in levels of proopiomelanocortin and corticotropin-releasing hormone-receptor 1 mRNAs in the pituitary and hypothalamus of the rat during chronic 'binge' cocaine and withdrawal. Zhou Y; Spangler R; Schlussman SD; Ho A; Kreek MJ Brain Res; 2003 Feb; 964(2):187-99. PubMed ID: 12576179 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]